Stefanie Sarantopoulos, MD, PhD

Associate Professor of Medicine
Assistant Professor of Immunology
Member of the Duke Cancer Institute
Campus mail 152 Jones Bldg, Box 3961, Durham, NC 27710
Email address stefanie.sarantopoulos@duke.edu
In Their Words

Education and Training

  • Fellowship, Hematology/ Oncology, Dana Farber Cancer Institute, 2002 - 2005
  • Chief Resident, Internal Medicine, Boston University School of Medicine, 2001 - 2002
  • Resident, Internal Medicine, Boston University School of Medicine, 1999 - 2001
  • Intern, Internal Medicine, Boston University School of Medicine, 1998 - 1999
  • Ph.D., Boston University School of Medicine, 1998
  • M.D., Boston University, 1998

Publications

Wolff, D, Greinix, H, Lee, SJ, Gooley, T, Paczesny, S, Pavletic, S, Hakim, F, Malard, F, Jagasia, M, Lawitschka, A, Hansen, JA, Pulanic, D, Holler, E, Dickinson, A, Weissinger, E, Edinger, M, Sarantopoulos, S, and Schultz, KR. "Biomarkers in chronic graft-versus-host disease: quo vadis?." Bone Marrow Transplantation 53, no. 7 (July 2018): 832-837.

PMID
29367715
Full Text

Anand, S, and Sarantopoulos, S. "Chronic Graft-versus-Host Disease: A Long Road Ahead." Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation 24, no. 3 (March 2018): 423-424.

PMID
29353108
Full Text

Zeiser, R, Sarantopoulos, S, and Blazar, BR. "B-cell targeting in chronic graft-versus-host disease." Blood 131, no. 13 (March 2018): 1399-1405. (Review)

PMID
29437591
Full Text

Sarantopoulos, S. "Allogeneic Stem-Cell Transplantation - A T-Cell Balancing ACT." The New England Journal of Medicine 378, no. 5 (February 2018): 480-482.

PMID
29385359
Full Text

Poe, JC, Jia, W, Su, H, Anand, S, Rose, JJ, Tata, PV, Suthers, AN, Jones, CD, Kuan, PF, Vincent, BG, Serody, JS, Horwitz, ME, Ho, VT, Pavletic, SZ, Hakim, FT, Owzar, K, Zhang, D, Blazar, BR, Siebel, CW, Chao, NJ, Maillard, I, and Sarantopoulos, S. "An aberrant NOTCH2-BCR signaling axis in B cells from patients with chronic GVHD." Blood 130, no. 19 (November 2017): 2131-2145.

PMID
28851699
Full Text

Anand, S, Thomas, S, Corbet, K, Gasparetto, C, Long, GD, Lopez, R, Morris, AK, Rizzieri, DA, Sullivan, KM, Sung, AD, Sarantopoulos, S, Chao, NJ, and Horwitz, ME. "Adult Umbilical Cord Blood Transplantation Using Myeloablative Thiotepa, Total Body Irradiation, and Fludarabine Conditioning." November 2017.

PMID
28729147
Full Text

Poe, J, diPaolo, J, Jia, W, Kim, JY, Su, H, Reyes, N, Marcondes, AM, Saban, D, Cardona, D, Anand, S, Cardones, A, Chao, N, and Sarantopoulos, S. "Oral Syk inhibitor, Entospletinib (GS-9973), controls disease and enhances survival in a mouse model of chronic graft-versus host disease (cGVHD)." 43rd Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT). Marseille, FRANCE. March 26, 2017 - March 29, 2017.: NATURE PUBLISHING GROUP, July 1, 2017.

Scholars@Duke

Poe, J, diPaolo, J, Jia, W, Kim, JY, Su, H, Reyes, N, Marcondes, AM, Saban, D, Cardona, D, Anand, S, Cardones, A, Chao, N, and Sarantopoulos, S. "Oral Syk inhibitor, Entospletinib (GS-9973), controls disease and enhances survival in a mouse model of chronic graft-versus host disease (cGVHD)." 43rd Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT). Marseille, FRANCE. March 26, 2017 - March 29, 2017.: NATURE PUBLISHING GROUP, July 1, 2017.

Scholars@Duke

Anand, S, Thomas, S, Hyslop, T, Adcock, J, Corbet, K, Gasparetto, C, Lopez, R, Long, GD, Morris, AK, Rizzieri, DA, Sullivan, KM, Sung, AD, Sarantopoulos, S, Chao, NJ, and Horwitz, ME. "Transplantation of Ex Vivo Expanded Umbilical Cord Blood (NiCord) Decreases Early Infection and Hospitalization." Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation 23, no. 7 (July 2017): 1151-1157.

PMID
28392378
Full Text

Saliba, RM, Sarantopoulos, S, Kitko, CL, Pawarode, A, Goldstein, SC, Magenau, J, Alousi, AM, Churay, T, Justman, H, Paczesny, S, Reddy, P, and Couriel, DR. "B-cell activating factor (BAFF) plasma level at the time of chronic GvHD diagnosis is a potential predictor of non-relapse mortality." Bone marrow transplantation 52, no. 7 (July 2017): 1010-1015.

PMID
28481353
Full Text

Pages